26 March 2021 In-depth: SA at cutting edge of TB vaccine research

26 Mar 2021 - 19:30

Today, on the 26 March 2001 the 1st participant in the first SATVI BCG- randomised clinical trial was enrolled. Adele Baleta writes in the Daily Maverick about the work that the South African Tuberculosis Vaccine Initiative has been doing the past 20 years in fighting TB. 

It is a hundred years since the BCG vaccine, the only registered vaccine proven to offer some protection against tuberculosis  (TB), was first used in people. Now researchers in South Africa are at the forefront of clinical trials testing experimental new TB vaccines. Adele Baleta reports in the Daily Maverick.

Read online.